Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

In Office Procedural Management of Hidradenitis Suppurativa

Description

The presentation addresses the in-office procedural management of Hidradenitis Suppurativa (HS), outlining effective strategies to enhance patient care. The speaker emphasizes the importance of combining medical and procedural treatments to improve outcomes for patients experiencing HS. Several case studies are used to illustrate various procedural options. For example, laser hair removal is noted as beneficial for patients with early-stage HS, particularly in reducing flare-ups related to shaving and sweating, with the 1064 ND YAG laser showing the most promising results. Botulinum toxin is also discussed as a viable option for managing hyperhidrosis and overall symptom relief. The speaker introduces intralesional triamcinolone (ILTAC) for treating inflamed nodules and abscesses, highlighting its rapid effectiveness in pain reduction. The need for incision and drainage is acknowledged for painful abscesses, although the recurrence rate can be high. Surgical de-roofing is suggested for recurrent lesions that have not responded to medical therapy, with lower recurrence rates compared to standard excisions. Lastly, the presentation reassures healthcare providers that they can perform these procedures successfully in their offices with minimal equipment and that patient satisfaction remains high.

View more

Conclusions

  • Combining medical and procedural management improves outcomes for patients with hidradenitis suppurativa (HS).
  • Laser hair removal is most effective for early-stage HS, particularly in the inguinal and axillary regions, requiring multiple sessions for optimal results.
  • Botulinum toxin can be beneficial for HS patients regardless of hyperhidrosis status, improving lesions and quality of life.
  • Intralesional triamcinolone (IL-TAC) can provide rapid relief for inflamed nodules and abscesses in HS, especially at higher doses.
  • Utilizing a punch tool during incision and drainage (I&D) can enhance procedure effectiveness and reduce pain.
  • Surgical deroofing is effective for recurrent HS lesions with a lower recurrence and complication rate compared to standard excisions, leading to high patient satisfaction.
  • Shih et al. Cutis. 2021.
  • McPhie et al. J Cutan Med Surg. 2019.
  • Elston. JAAD. 2023.
  • Bechara et al. JAMA Surg. 2021.
  • Tierney et al. Dermatol Surg. 2009.
  • Mahmoud et al. JAAD. 2010.
  • Hamzavi et al. JAAD. 2015.
  • Naouri et al. JAAD. 2021.
  • Xu et al. Arch Dermatol. 2011.
  • Vossen et al. JDDG. 2018.
  • Orenstein et al. Dermatology. 2020.
  • Tripathi et al. JAAD. 2022.
  • Thompson et al. BJD. 2021.
  • Shih et al. Dermatol Therapy. 2022.
  • Grimstad, et al. Am J Clin Dermatol. 2020.
  • Campanati et al. Dermatologic Therapy. 2019.
  • Riis et al. JAAD. 2016.
  • Cuenca-Barrales et al. Dermatology. 2022.
  • Garelik et al. Int J Dermatol. 2020.
  • Salvador-Rodriguez, et al. Sci Rep. 2020.
  • lannone et al. Dermatol Ther. 2021.
  • Ravi et al. JAMA Dermatol. 2022.
  • Saylor et al. Dermatol Ther. 2020.
  • Brownstone et al. JAAD. 2020.
  • Blum et al. JAAD. 2021.